Investors



  • FOR INFORMATION ON
    THE PROPOSED COMBINATION WITH MEDTRONIC, click here.


  • FOR INFORMATION ON
    REPORTING CHANGES AND
    REVISED REVENUE GUIDANCE click here.


  • FOR GIVEN IMAGING
    ACQUISITION INFORMATION, click here.


  • FOR 2013 INVESTOR DAY MATERIALS,
    click here.


  • For Pharmaceuticals
    spin-off information,
    click here.


  • For tax basis information
    due to the Mallinckrodt spin,
    click here.


Investor Relations Home

Recent News More >>
Covidien Announces Dividend Increase - 09/17/14
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 17, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 13% increase in the quarterly dividend rate, from $0.32 per ordinary share to $0.36 per ... More >>
Covidien Announces Start of Enrollment in Two Neurovascular Clinical Trials - 09/15/14
DUBLIN, Ireland--(BUSINESS WIRE)--Sep. 15, 2014-- Covidien plc announced today the start of enrollment in two clinical trials designed to further underscore the safety and effectiveness of the company’s advanced neurovascu... More >>
Covidien Acquires Venous Disease Treatment Developer Sapheon, Inc. - 08/28/14
Transaction expands Covidien’s market leading portfolio with next generation technology for treatment of varicose veins DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 28, 2014-- Covidien plc (NYSE: COV) today announced that it... More >>
Upcoming EventsMore >>
There are currently no events scheduled.
September 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-11234
09/04/14
425
Formats:  HTML Adobe PDF Word
5
09/05/14
425
Formats:  HTML Adobe PDF Word
6
78910
09/10/14
425
Formats:  HTML Adobe PDF Word
111213
14151617181920
21222324252627
28293051525354
Featured Report
Download Documentation 2013 Annual Report
What's New

Stock Quote

COV (Common Stock)
ExchangeNYSE
(US Dollar)
Price$91.15
Change (%) Stock is Down 0.51
 (0.56%)
Volume4,090,731
As of 09/17/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Tool Kit

Printer Friendly Version    Printer-friendly version
E-mail this page   E-mail this page
RSS    RSS Feeds
E-mail Alerts Receive E-mail Alerts
View contacts     View contacts